Picture EasyFairs Connect in Pharma 2023 Geneva 650x89px
Document › Details

Cobo Technologies ApS. (4/23/19). "News: Welcome to Our New COO, Hasse Herlevsen".

Organisations Organisation Cobo Technologies ApS
  Organisation 2 Leo Pharma A/S
  Group Leo Pharma (Group)
Product Product PIPPR® protein expression analysis platform
  Index term 2 United States (govt)–Cobo Technologies: genome editing, 201904– collab Cobo beomes member of NIST Genome Editing Consortium
Person Person Herlevsen, Hasse (Cobo Technologies 201904– COO + Co-Owner before Leo Pharma)

To further strengthen our expertise within the Quality Control field, Hasse Herlevsen (former Corp. VP Quality, LEO Pharma) will join our team as COO.

Hasse will be responsible for the daily operation including all internal/external QC related projects. In addition he will also lead our membership in the NIST - Genome Editing Consortium and advise customers about standards and guidelines within the CRISPR Medicine field.

Record changed: 2019-07-09


Picture EasyFairs Connect in Pharma 2023 Geneva Networking 650x200px

More documents for Cobo Technologies ApS

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture EBD Group BIO-Europe 2023 Munich BEU23 650x300px

» top